1 recruiting, 1 terminated, 1 unknown. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Recruiting 1, Terminated 1, Unknown 1 |
Follow DEB-TACE: new trials by email Literature Review of DEB-TACE trials Research Report on DEB-TACE
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| DEB-TACE vs cTACE in HCC After TIPS DEB-TACE, cTACE - Hepatocellular Carcinoma (HCC), TACE | Phase 3 | Recruiting | First Affiliated Hospital, Sun Yat-Sen University | 206 | 2025-12-01 | 2026-05-01 |
| Transarterial Embolization Alone Versus Drug-Eluting Beads Chemoembolization for Hepatocellular Carcinoma DEB-TACE, TAE - Carcinoma, Hepatocellular | Phase 3 | Unknown | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 154 | 2019-12-04 | 2021-03-19 |
| A Study of ONCO-DOX in Locally Advanced Hepatocellular Carcinoma DEB-TACE, Sorafenib - Hepatocellular Carcinoma, Hepatoma | Phase 3 | Terminated | Boston Scientific Corporation | 2 | 2015-11-01 | 2021-02-12 |
Boston Scientific Corporation (1) · First Affiliated Hospital, Sun Yat-Sen University (1) · IRCCS Azienda Ospedaliero-Universitaria di Bologna (1)
China (1) · Italy (1) · United States (1)
Anastasia Becker (1) · Rita Golfieri, Professor (1)